Literature DB >> 21891973

Binding of curcumin to senile plaques and cerebral amyloid angiopathy in the aged brain of various animals and to neurofibrillary tangles in Alzheimer's brain.

Mayu Mutsuga1, James Kenn Chambers, Kazuyuki Uchida, Meina Tei, Takao Makibuchi, Tatsuya Mizorogi, Akihiko Takashima, Hiroyuki Nakayama.   

Abstract

The binding of curcumin to senile plaques (SPs) and cerebral amyloid angiopathy (CAA) was examined in the aged brain of various animal species and a human patient with Alzheimer's disease (AD), together with its binding to neurofibrillary tangles (NFTs). Brain sections were immunostained with anti-amyloid β protein 1-42 (Aβ42) and anti-amyloid β protein 1-40 (Aβ40) antibodies. These sections were also stained with alkaline Congo red, periodic acid-methenamine silver (PAM), and curcumin (0.009% curcumin solution) with or without formic acid pretreatment. The sections from the AD brain were also immunostained for anti-paired helical filament-tau (PHF-tau), and were stained with Gallyas silver for NFTs. Some SPs in the AD, monkey, dog, bear, and amyloid precursor protein transgenic mouse (APP Tg-mouse) brains contained congophilic materials, and were intensely positive for curcumin. In addition, curcumin labeled some diffuse SPs negative for Congo red in the AD, monkey, bear, and APP Tg-mouse brains. In all animals, CAA was intensely positive for both Congo red and curcumin. The specific curcumin staining activity was lost by formic acid pretreatment. In the AD brain, NFTs positive for PHF-tau and Gallyas silver were moderately stained with curcumin. These findings indicate that curcumin specifically binds to the aggregated Aβ molecules in various animals, and further to phosphorylated tau protein, probably according to its conformational nature.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21891973     DOI: 10.1292/jvms.11-0307

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  23 in total

1.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

2.  Curcumin Dictates Divergent Fates for the Central Salt Bridges in Amyloid-β40 and Amyloid-β42.

Authors:  Bappaditya Chandra; Venus Singh Mithu; Debanjan Bhowmik; Anand Kant Das; Bankanidhi Sahoo; Sudipta Maiti; Perunthiruthy K Madhu
Journal:  Biophys J       Date:  2017-04-25       Impact factor: 4.033

Review 3.  Clinical development of curcumin in neurodegenerative disease.

Authors:  Shuxin Hu; Panchanan Maiti; Qiulan Ma; Xiaohong Zuo; Mychica R Jones; Greg M Cole; Sally A Frautschy
Journal:  Expert Rev Neurother       Date:  2015-06       Impact factor: 4.618

4.  A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.

Authors:  Panchanan Maiti; Tia C Hall; Leela Paladugu; Nivya Kolli; Cameron Learman; Julien Rossignol; Gary L Dunbar
Journal:  Histochem Cell Biol       Date:  2016-07-12       Impact factor: 4.304

5.  Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.

Authors:  Yosef Koronyo; David Biggs; Ernesto Barron; David S Boyer; Joel A Pearlman; William J Au; Shawn J Kile; Austin Blanco; Dieu-Trang Fuchs; Adeel Ashfaq; Sally Frautschy; Gregory M Cole; Carol A Miller; David R Hinton; Steven R Verdooner; Keith L Black; Maya Koronyo-Hamaoui
Journal:  JCI Insight       Date:  2017-08-17

6.  Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases.

Authors:  Zhiyou Cai; Zhou Liu; Ming Xiao; Chuanling Wang; Fuming Tian
Journal:  Neurochem Res       Date:  2017-08-24       Impact factor: 3.996

Review 7.  Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.

Authors:  Cátia Janota; Cynthia A Lemere; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2015-07-05       Impact factor: 5.590

Review 8.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors:  Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

9.  A combination cocktail improves spatial attention in a canine model of human aging and Alzheimer's disease.

Authors:  Elizabeth Head; Heather L Murphey; Amy L S Dowling; Katie L McCarty; Samuel R Bethel; Jonathan A Nitz; Melanie Pleiss; Jenna Vanrooyen; Mike Grossheim; Jeffery R Smiley; M Paul Murphy; Tina L Beckett; Dieter Pagani; Frederick Bresch; Curt Hendrix
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

10.  Neurofibrillary tangles and the deposition of a beta amyloid peptide with a novel N-terminal epitope in the brains of wild Tsushima leopard cats.

Authors:  James K Chambers; Kazuyuki Uchida; Tomoyuki Harada; Masaya Tsuboi; Masumi Sato; Masahito Kubo; Hiroaki Kawaguchi; Noriaki Miyoshi; Hajime Tsujimoto; Hiroyuki Nakayama
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.